tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Artrya Limited Advances U.S. Market Entry with Strategic Milestones

Story Highlights
  • Artrya Limited launched its Salix® platform in the U.S. and submitted its Plaque module for FDA clearance.
  • The company secured a $0.6M contract with Tanner Health, marking its first U.S. commercial revenues.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Artrya Limited Advances U.S. Market Entry with Strategic Milestones

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Artrya Limited ( (AU:AYA) ) just unveiled an announcement.

Artrya Limited has made significant strides in its commercial operations, highlighted by the U.S. launch of its Salix® Coronary Anatomy platform and the submission of its Salix® Coronary Plaque module for FDA clearance. The company secured a five-year contract with Tanner Health, marking its first U.S. commercial revenues, and is preparing for further expansion with strategic partnerships and a clear reimbursement pathway. The leadership transition, with Co-Founder John Konstantopoulos appointed as CEO, aims to drive the company’s transition to a commercially led enterprise, focusing on integrating U.S. and Australian hospital partners and expanding its product utility and revenue base.

The most recent analyst rating on (AU:AYA) stock is a Buy with a A$2.21 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.

More about Artrya Limited

Artrya Limited is a medical technology company that specializes in the commercialisation of its AI-powered Salix® cloud platform for the assessment and management of coronary artery disease. The company focuses on providing real-time, point-of-care cardiac analysis globally, with a significant market focus in the United States and Australia.

Average Trading Volume: 216,253

Technical Sentiment Signal: Buy

Find detailed analytics on AYA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1